Return on Equity (ROE)
Updated 56h ago
Sector Performance
62th percentileLIN
18.2%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how efficiently a company generates profit from shareholders’ equity — a higher ROE indicates better use of investor capital.
LIN’s current ROE of 18.2% sits above the sector median of 13.8%, placing it in the 62th percentile among its peers, meaning it outperforms the majority of similar companies. However, the trend data is not available: the year-over-year change is N/A and the quarter-over-quarter change is N/A, so no directional insight can be drawn from recent history. The combination of an above-median ROE with no trend information suggests a neutral risk-opportunity profile — the level is positive, but the lack of change data limits confidence in sustainability. This metric supports the overall NEUTRAL verdict because the favorable relative performance is offset by the absence of any trend to confirm momentum or deterioration.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about LIN?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are LIN's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master LIN's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full LIN research report →LIN
18.2%
Sector Median
13.8%
Sector Avg
31.4%
How LIN's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.